EKSO Q3 2020 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$30M

Q3 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$3M-12.7% YoY

Gross Profit

$2M62.6% margin

Operating Income

-$2M-83.6% margin

Net Income

$2M84.6% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

+28.0%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$573,000

Balance Sheet

Total Assets

$23M

Total Liabilities

$15M

Stockholders' Equity

$8M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	-12.7%
Gross Profit	$2M	$2M	+3.6%
Operating Income	-$2M	-$4M	+36.1%
Net Income	$2M	$206,000	+1090.3%

Revenue Segments

EksoHealth

$3M95%

EksoWorks

$158,0005%

Geographic Segments

UNITED STATES

$2M66%

Non-US

$971,00034%